This press release contains forward-looking statements about Paramount, Chem Rx and their combined business after completion of the proposed business combination. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are based upon the current beliefs and expectations of Paramount's management and are subject to risks and uncertainties that could cause actual results to differ from the forward- looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: compliance with government regulations; changes in legislation or regulatory environments; requirements or changes adversely affecting the health care industry, including changes in Medicare reimbursement policies; fluctuations in customer demand; management of rapid growth; intensity of competition; timing, approval and market acceptance of new product introductions; general economic conditions; geopolitical events and regulatory changes, as well as other relevant risks detailed in Paramount's filings with the SEC, including its Annual Report on Form 10-KSB for the year ended December 31, 2006. The information set forth herein should be read in light of such risks. Paramount does not assume any obligation to update the information contained in this press release.
Additional information concerning the transaction is included in the
preliminary proxy statement originally filed by Paramount with the SEC on
June 18, 2007, and amended on August 13, 2007, and the Current Report on
Form 8-K originally filed on June 4, 2007, and amended on July 2, 2007, by
Paramount with the SEC. STOCKHOLDERS OF PARAMOUNT AND OTHER INTERESTED
PERSONS ARE ADVISED TO READ
|SOURCE Paramount Acquisition Corp.|
Copyright©2007 PR Newswire.
All rights reserved